本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ICU醫療

157.60
+1.120.72%
盤後157.700.1000+0.06%19:30 EDT
成交量:18.99萬
成交額:2,989.33萬
市值:39.39億
市盈率:130.93
高:158.68
開:157.63
低:155.74
收:156.48
52周最高:192.85
52周最低:112.50
股本:2,499.24萬
流通股本:2,451.32萬
量比:0.84
換手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):1.20
每股收益(LYR):0.0297
淨資產收益率:1.41%
總資產收益率:1.93%
市淨率:1.83
市盈率(LYR):5,305.15

資料載入中...

2025/02/28

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/18

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]